Problems with the Boeing capsule forced them to extend their stay, but they remained confident in the craft. ‘We’re going to make it work,’ said Butch Wilmore.
An employee of the FDA’s Center for Biologics Evaluation and Research says the agency rushed a first-of-its-kind medical product to market prematurely.